Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | MMP9 | P14780 | 1/20 | 0.54 |
| ▸ | F7 | P08709 | 3/20 | 0.46 |
| ▸ | F3 | P13726 | 3/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1551778 | 1.00 | ALDH1A1 (0.54) | ALDH1A1ALOX15KDM4ELMNATSHR | |
| SCHEMBL247028 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ALOX15KDM4ELMNATSHR | |
| SCHEMBL3490050 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ALOX15KDM4ELMNATSHR | |
| SCHEMBL16503992 | 0.95 | ALDH1A1 (0.50) | ALDH1A1ALOX15KDM4ELMNATSHR | |
| SCHEMBL23294916 | 0.93 | ALDH1A1 (0.58) | ALDH1A1ALOX15KDM4ELMNATSHR | |
| SCHEMBL8985903 | 0.93 | ALDH1A1 (0.58) | ALDH1A1ALOX15KDM4ELMNATSHR | |
| SCHEMBL21626134 | 0.93 | ALDH1A1 (0.58) | ALDH1A1ALOX15KDM4ELMNATSHR | |
| SCHEMBL1046506 | 0.89 | FAAH (0.54) | ALDH1A1ALOX15KDM4ELMNATSHR | |
| SCHEMBL4450423 | 0.89 | FAAH (0.54) | ALDH1A1ALOX15KDM4ELMNATSHR | |
| SCHEMBL1046505 | 0.89 | FAAH (0.54) | ALDH1A1ALOX15KDM4ELMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12465580-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | BASF AS (NO) | 2025-11-11 | — | — | US | disclosed |
| EP-3288550-B1 | STRUCTURALLY ENHANCED FATTY ACIDS CONTAINING SULPHUR FOR THEIR USE IN TREATING NON-ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2024-06-05 | — | — | EP | disclosed |
| US-20240156760-A1 | SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2024-05-16 | — | — | US | disclosed |
| US-11911354-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | BASF (NO) | 2024-02-27 | — | — | US | disclosed |
| US-11911354-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | BASF (NO) | 2024-02-27 | — | — | US | disclosed |
| US-11911354-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | BASF (NO) | 2024-02-27 | — | — | US | disclosed |
| CN-115025079-A | Use of structurally enhanced sulfur-containing fatty acids for the prevention and/or treatment of non-alcoholic steatohepatitis | 普罗诺瓦生物医药挪威公司 | 2022-09-09 | — | — | CN | disclosed |
| US-20220280459-A1 | SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2022-09-08 | — | — | US | disclosed |
| US-20220280459-A1 | SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2022-09-08 | — | — | US | disclosed |
| US-11234948-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | BASF AS (NO) | 2022-02-01 | — | — | US | disclosed |
| US-20140316002-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-10-23 | — | — | US | disclosed |
| US-8759558-B2 | Sulphur containing lipids for use as food supplement or as medicament | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-06-24 | — | — | US | disclosed |
| US-8759558-B2 | Sulphur containing lipids for use as food supplement or as medicament | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-06-24 | — | — | US | disclosed |
| US-8759558-B2 | Sulphur containing lipids for use as food supplement or as medicament | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-06-24 | — | — | US | disclosed |
| US-20110190395-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2011-08-04 | — | — | US | disclosed |
| US-20110190395-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2011-08-04 | — | — | US | disclosed |
| US-20110190395-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2011-08-04 | — | — | US | disclosed |
| EP-2313090-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | Pronova BioPharma Norge AS (NO) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010008299-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-01-21 | — | — | WO | disclosed |
| WO-2010008299-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12465580-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | SLC10A1, LIPC, FABP1 | ALDH1A1 443/4885ALOX15 166/4885KDM4E 2114/4885 |
| US-20140316002-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | SGMS2, SGMS1, ACSS2 | ALDH1A1 514/4885ALOX15 226/4885KDM4E 2212/4885 |
| US-20240156760-A1 | SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | SLC10A1, LIPC, FABP1 | ALDH1A1 443/4885ALOX15 166/4885KDM4E 2114/4885 |
| US-11234948-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | SLC10A1, LIPC, FABP1 | ALDH1A1 443/4885ALOX15 166/4885KDM4E 2114/4885 |
| US-20110190395-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | SGMS2, SGMS1, ACSS2 | ALDH1A1 514/4885ALOX15 226/4885KDM4E 2212/4885 |
| US-20220280459-A1 | SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | SLC10A1, LIPC, FABP1 | ALDH1A1 443/4885ALOX15 166/4885KDM4E 2114/4885 |
| US-11911354-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | SLC10A1, LIPC, FABP1 | ALDH1A1 443/4885ALOX15 166/4885KDM4E 2114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.